NCI Standard Funding Opportunity Announcements
|
Current and Recent
Program Announcements |
Current and Recent
Requests for Applications |
Current
and Recent NCI and Trans-NIH Initiatives |
Requests for Proposals
|
Standard Due Dates
|
|
Ongoing |
All Ranks |
Federal |
See BAA |
Army Research Office Broad Agency Announcement (BAA)
Basic and Applied Scientific Research
The purpose of this BAA is to solicit research proposals in the
engineering, physical, life, and information sciences for
submission to the Army Research Office (ARO) for consideration
for possible funding.
Due Dates: |
Open until March 31, 2017
Proposers are to submit white papers prior to submission of a
complete proposal. Based on assessment of white papers, feedback will be
provided to encourage or discourage submission of full proposals. |
Amount & Project Period: |
No specific dollars have been reserved 3
years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Links: |
ARO CORE
BAA-W911NF-12-R-0012-Mod 03
Army Research
Laboratory BAAs |
|
NEW |
Ongoing |
All Ranks |
Non-federal |
Research Funding |
Alfred P. Sloan Foundation
Research Funding - Basic Research/Digital Information
Technology
Among 7 program areas are:
Basic Research - Grants in this area promise to
substantively benefit society or significantly add to the body
of scientific knowledge
Digital Information Technology - This program
seeks to better understand relationships between technology,
information, and society, primarily through research on and
development of digital information technology for conduct of
scholarly research and public engagement with knowledge.
|
|
May 01 |
Jr Faculty |
Moffitt |
Career Development |
MMG Junior Faculty Research Award
The MMG Junior Faculty Research Award (JFRA) is intended to ease
transition to independence for investigators either in the
laboratory or as clinical trialists. Award promotes exploration
of innovative ideas in translational research through the
funding of pilot projects proposed by Moffitt investigators;
will not support extensions of existing full projects. The goal
is to allow appropriate and motivated individuals to develop an
independent research career in translational science focused on
cancer.
|
|
May 01 |
All Ranks |
Non-federal |
Cellular & Molecular Imaging |
Robarts Research Institute
2015 J. Allyn Taylor International Prize in Medicine
This prize is awarded annually to one or more individuals who
have made significant contributions in basic or clinical
research. The 2015 Prize will be granted to a scientist who has
made outstanding contributions in the area of Cellular
and Molecular Imaging in Cancer.
Due Dates: |
May 01 |
Amount & Project Period: |
All Ranks |
Eligibility: |
$25,000 - prize |
Contact: |
Linda Nolan (x6071) |
Link: |
Overview |
|
|
May 01 (LOI) |
Postdocs |
Non-Federal |
Hematology |
American Society of Hematology (ASH) Scholar Award
Support for critical period required for completion of
training and achievement of status as an independent
investigator See
website for specific Basic/Translational and Clinical
research areas for ASH.
Due Dates: |
May 01 (Letter of Intent)
Invited Applications: July 30 (OSR) Ι August 03 (Sponsor) |
Amount & Project Period: |
Fellow Scholars:
$100,000 over a 2-3 year award
Jr. Faculty Scholars:
$150,000 over a 2-3 year award |
Eligibility: |
As of LOI submission:
Fellows:
<5 years of research
experience after completion of PhD
MDs:
>3
but <5 years of
research experience
Jr. Faculty Scholar: MD, PhD
or MD/PhD applicants >5
but <10 years research
experience after completion of PhD
1. Applicants with the title of Assistant Professor or equivalent
*must* apply for the Junior Faculty Award, regardless of
research experience.
2. All candidates required to be members of ASH in good standing for
duration of program |
Contact: |
Fellow Scholars: $100,000 over a 2-3 year award
Jr. Faculty Scholars: $150,000 over a 2-3 year award |
Link: |
Scholar Awards |
|
|
May 01 (LOI) |
All Faculty |
Non-federal |
Drug Discovery |
The Harrington Discovery Institute
University Hospitals Case Medical Center
Harrington Scholar-Innovator Program
The goal is to advance physician-scientist-initiated projects
aimed at clinical introduction of new medicines (drugs or
biologics). Specific focus of eligible projects includes
fundamental discovery (elucidation of novel targets and leads)
or development of novel drugs or biologics or drug-device
combinations
Due Dates: |
May 01 (Letter of Intent)
Invited Applications: July 30 (OSR) Ι August 03 (Sponsor) |
Amount & Project Period: |
Up to $700,000 - 2 years
($100,000 guaranteed) |
Eligibility: |
Must be a faculty physician-scientist, MD or
MD/PhD
No multiple PIs allowed |
Contact: |
Linda
Nolan (x6071) |
Link: |
Harrington Scholar-Innovator Grant |
|
|
May 03 (LOI) |
All Ranks |
Federal |
BD2K |
Big Data to Knowledge (BD2K) Advancing Biomedical Science
Using Crowdsourcing and Interactive Digital Media
Supports development of new or significantly adapted interactive digital
media that engage the public in performing some aspect of
biomedical research via crowdsourcing. To be responsive,
application is expected to pose a challenging biomedical
research problem and propose development of engaging interactive
digital media that incorporate crowdsourcing as a fundamental
component of how the problem is solved.
Due Dates: |
May 03 (Letter of Intent) June 01 (OSR) Ι
June 03 (Sponsor) |
Amount & Project Period: |
Not to exceed $200,000/year (Direct Costs) - 2
years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-CA-15-006 |
|
|
May 06 (Pre-app) |
All Faculty |
Federal |
Ovarian Cancer |
Congressionally Directed Medical
Research Programs (CDMRP)
Ovarian Cancer Research Program (OCRP)
Due Dates: |
May 06 (Pre-application)
Invited Submissions: August 03 (OSR) Ι August 05 (Sponsor) |
Contact: |
Linda Nolan
(x6071) |
Pilot Award - W81XWH-15-OCRP-PA
|
Supports innovative, high-risk/high-reward research that could ultimately
lead to critical discoveries or major advancements that will
drive ovarian cancer research forward Innovation and Impact are
important review criteria Preliminary data are not required, but
allowed Clinical trials are not allowed
Amount & Project Period: |
$250,000 (Direct Costs) - 2 years |
Eligibility: |
Investigators at or above postdoc level (or
equivalent) |
Program Announcement Link: |
DoD Ovarian Cancer Pilot Award |
Clinical Translational Award - W81XWH-15-OCRP-CTA
|
Supports translational research addressing high-impact
ideas in ovarian cancer
Supports pre-clinical and clinical research, and clinical trial-related
research
Clinical trials are not allowed Can be used to support research projects
related to/associated w/ongoing or completed clinical trials supported
by other funding sources
Preliminary data are required
|
|
|
May 08 (LOI) |
All Ranks |
Federal |
Prevention/Control - LMICs |
Administrative Supplements to Promote Cancer Prevention and
Control Research in Low and Middle Income Countries
The NCI will provide administrative supplement awards to
currently-funded P30 NCI-designated cancer center grantees to
support pilot research plans that focus on cancer prevention and
control
Due Dates: |
May 08 I Letter of Intent) Ι June 04 (OSR) Ι
June 08 (Sponsor |
Amount & Project Period: |
$260,000 (Direct Costs) - 2 years (At least 50%
of proposed costs must be for the LMIC
institution) |
Eligibility: |
Parent award must be active and research
proposed must be accomplished w/in currently approved project period.
Period of supplement may not
include any anticipated period of no-cost extension for the parent
grant. Proposed research must be within original scope of NIH-supported
grant. |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
(PAR-15-155) |
|
NEW |
May 08 (LOI) |
See Below |
Non-federal |
Ovarian Cancer |
Ovarian Cancer Research Fund
Due Dates: |
May 08 (Letter of Intent) Must be submitted via
proposalCENTRAL
by 5:00pm ET
Invited Submissions: July 16 (OSR) Ι July 20 (Sponsor) |
Contact: |
Linda
Nolan (X6071) |
Ann Schreiber Mentored Investigator Award
Provides funding
for trainees who are working under the supervision of a mentor
who is a recognized leader in the field of ovarian cancer
research, or relevant area.
|
|
Liz Tilberis Early Career Award
For junior faculty with a strong commitment to an investigative
career in ovarian cancer research Awards support a substantial
time commitment to research and academic endeavors in ovarian
cancer.
Amount & Project Period: |
$150,000/year - 3 years |
Eligibility: |
Must have an M.D. or Ph.D. degree be in first 5
years of first academic appointment after completing fellowship or
post-doctoral training (Assistant Professor or equivalent).
If invited to submit a full proposal, applicants required to provide 2
letters of recommendation, including 1 from someone in a position to
mentor applicant |
Links: |
OCRF Current Grant Programs
2016 Tilberis Early Career Award LOI Application Guidelines |
|
|
Program Project Development Grant
Provides funds for large ovarian cancer research projects that involve
several investigators within one institution or collaborations
between groups in multiple institutions
|
NEW |
May 11 |
Faculty & Scientists |
Moffitt |
Core Technologies |
Moffitt Innovation and Technology
Committee (ITC)
Innovative Core Projects Award
To encourage early access to novel technologies before
commercially available and further Moffitt efforts to remain
on the forefront of discovery To provide dedicated research
time to develop a new technology or the operational procedures
of a new core instrument that will lead to new core services
Due Dates: |
May 11 by 4:00pm (email to
Brittany.Palermo@moffitt.org) |
Amount & Project Period: |
$60,000 - 1 year |
Eligibility: |
Moffitt Faculty, Staff Scientists, & Research
Scientists |
Contact: |
Brittany Palermo (x1536) for additional
information |
|
|
May 12 |
All Ranks |
Federal |
Prevention-Native Americans |
Interventions for Health Promotion and Disease
prevention in Native American Populations
Develop, adapt, and test the effectiveness of health promotion
and disease prevention interventions in Native American (NA)
populations
Due Dates: |
May 10 (OSR) Ι May 12
(Sponsor) |
Amount & Project Period: |
Budgets are not limited - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-14-260 |
|
|
May 13 (Pre-app) |
See Below |
Federal |
Career Development |
Congressionally Directed Medical Research Programs (CDMRP)
Ovarian Cancer Research Program (OCRP)
Due Dates: |
May 13 (Pre-application)
Invited Submissions: August 10 (OSR) Ι August 12
(Sponsor)
|
Contact: |
Linda Nolan
(x6071) |
Ovarian Cancer Academy Early-Career Investigator - W81XWH-15-OCRP-OCA
|
Early-Career Investigators for
unique, interactive virtual academy that provides intensive mentoring,
national networking, and a peer group for junior faculty
Preliminary data are required.
Institutional match of $50,000 per
year is required
Amount & Project Period: |
$725,000 (Direct Costs) -
5 years |
Eligibility: |
Must be
w/in first 3 years of first faculty appt. (or equiv) at submission
(Tenure or non-tenure track).
Must commit no less than 25% effort to this award for
first 2 years and have an overall 50% protected time for research |
Program
Announcement Link: |
DoD Ovarian Cancer Academy - Early-Career Investigator
|
Investigator-Initiated Research Award
-
W81XWH-15-OCRP-IIRA
|
|
Supports meritorious basic and clinically oriented research in
ovarian cancer with impact is an important review criterion.
Preliminary data are required. Clinical trials are not allowed.
Pilot awardees (past & present) are encouraged to apply.
Amount & Project Period: |
$450,000 (Direct Costs) - 3 years |
Eligibility: |
Independent investigator at or above Assistant
Professor (or equiv) level |
Program Announcement Link: |
FY15 OCRP IIRA Program Announcement |
|
NEW |
May 14 (LOI) |
Postdocs |
Non-federal |
Career Development |
Mathilde Krim Fellowships in Basic Biomedical Research
The goal is to facilitate postdoctoral transition
to productive and independent long-term career in HIV/AIDS
research. Applicants must conduct basic biomedical research on
HIV/AIDS to be considered for funding in this program.
Due Dates: |
May 14 (Letter of Intent) by 3:00pm (EDT)
Invited Applications: July 29 (OSR) Ι July 31 (Sponsor) |
Amount & Project Period: |
$150,000 (TOTAL) - 2 years |
Eligibility: |
Postdocs w/research or clinical doctorate
completed 3 to 6 years prior to April 17, 2015 (for applicants who
have earned only an M.D. begins w/date internship finished)
Be positioned to secure independent research position by March 2018
Be main author on significant publications in leading international
peer-reviewed journals
Have made oral and poster presentations at major scientific conferences
and meetings |
Contact: |
Linda
Nolan (X6071) |
Link: |
Mathilde Krim Fellowships |
|
|
May 15 (LOI) |
All Ranks |
Federal |
Conference Support |
FY15 Announcement of the Anticipated Availability of Funds
for Research Conferences on Research Integrity
Conferences or workshops must be designed to provide a forum for
discussion and produce tangible outcomes related to at least one
of the following themes:
1) Responsible conduct of research training;
2) Fostering an environment promoting research
integrity;
3) Prevention of research misconduct;
4) Handling of research misconduct allegations;
5) Whistleblowing;
6) International issues in research integrity;
7) Other topics linked to research integrity and
compliance
Due Dates: |
May 13 (OSR) Ι May 15 (Sponsor) |
Amount & Project Period: |
$50,000 - 1 year |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
IR-ORI-15-002 |
|
|
May 15 (LOI) |
All Ranks |
Federal |
Lung Imaging |
Molecular Imaging of the Lung - Phase 2
Supports studies that advance translation of identified probes
and associated imaging approaches from animal models into
applicability for human lung diseases Studies must include work
performed in vivo using appropriate animal models of lung
disease and studies using human tissues and/or cells.
Applications proposing Investigational New Drug (IND)-enabling
studies of novel probes and imaging approaches are encouraged.
Due Dates: |
May 15 (Letter of Intent) Ι June 11
(OSR) Ι June 15 (Sponsor) |
Amount & Project Period: |
$450,000/year (Direct Costs) - 3 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-HL-16-001 |
|
NCI is a participating institute
|
May 16 |
All Ranks |
Federal |
Obesity |
Exploratory/Developmental Clinical Research Grants in
Obesity
To conduct exploratory/developmental clinical studies
accelerating development of effective interventions for
prevention or treatment of overweight or obesity in adults
and/or children. Exploratory epidemiological research with a
goal of informing translational/clinical research will also be
supported within this program.
Due Dates: |
Standard dates Ι June 12 (OSR) Ι June 16 (Sponsor) |
Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
(PA-15-163) |
|
|
May 17 (LOI) |
All Faculty |
Federal |
Population Science & Cancer |
Bridging the Gap Between Cancer
Mechanism and Population Science
Any project that poses and addresses a challenging cancer
question that can only be addressed by linking these two ends of
the cancer spectrum - biological mechanism and population.
Due Dates: |
May 17 (Letter of Intent) (also Oct. 4th)
June 15 (OSR) Ι June 17 (Sponsor) (also Nov. 4th) |
Amount & Project Period: |
$750,000/yr. (Direct Costs) - 5 years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-13-081 |
|
|
May 22 (LOI) |
All Ranks |
Federal |
Natural Product Testing |
Phased Innovation Award for Exploratory Clinical Trials of
Natural Products in NCCIH High Priority Research Topics
Supports pilot testing of natural products (i.e., botanicals,
dietary supplements, and probiotics), having sufficient
early-stage data to justify further clinical testing. Intention
is to speed translation of emerging basic science findings about
natural products into clinical pilot testing to determine
whether continued clinical research is warranted.
Due Dates: |
May 22 (Letter of Intent)
Applications: June 18 (OSR) Ι June 22 (Sponsor) |
Amount & Project Period: |
$275,000 (Total Direct Costs) - 2 years (R21)
$450,000 (Total Direct Costs) - 3 years (R33) |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-AT-16-001 |
|
Annual Due Date |
May 25 |
Al Faculty |
Federal |
Team Science |
Program Project Grants and Center Grants (New, Renewal,
Resubmission & Revision)
Program Project grants contain at least 3 component projects.
The individual projects may represent several disciplines and/or
address several discrete research aspects pertinent to 1 or more
disciplines. However, all of the projects must be relevant to
the common unifying central theme, focus, and the overall
objective of the entire program project. The individual
projects should be clearly interrelated and synergistic so that
the research ideas, efforts, and outcomes of the program as a
whole will offer a distinct advantage over pursuing the
individual projects separately.
Due Dates: |
May 21 (OSR) Ι May 25 (Sponsor) |
Amount & Project Period: |
Budgets are not limited - 5 years |
Eligibility: |
All Faculty |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-023 |
|
|
May 25 |
See Below |
Federal |
Cancer Education |
NCI Cancer Education Programs
Due Dates: |
Standard dates Ι May 21 (OSR) Ι May 25 (Sponsor) |
Contact: |
Linda
Nolan (x6071) |
Cancer Education Grants Program
To support innovative educational efforts that would help to reduce
cancer incidence, morbidity, and mortality, and that would improve the
quality of life of cancer patients.
Amount &
Project Period: |
$300,000/year (Direct Costs) - 5
years |
Eligibility: |
Established investigator in scientific area for
which application is targeted, and capable of providing administrative
and scientific leadership to development and implementation of proposed
program. |
FOA Link: |
PAR-12-049 |
Cancer Education Grants Program Curriculum or Methods Development
This FOA will support creative educational activities
with a primary focus on Curriculum or
Methods Development. Applications that propose innovative,
state-of-the-art programs, addressing the cause, diagnosis, prevention,
and treatment of cancer, rehabilitation from cancer, and the continuing
care of cancer patients and the families of cancer patients are
encouraged.
Amount & Project Period: |
$100,000/year (Direct Costs) - 3 years |
Eligibility: |
Established investigator at Associate Professor
level or above in scientific area in which application is targeted, and
capable of providing both administrative and scientific leadership to
development and implementation of proposed program. An application that
proposes to adapt a current or previously funded course to focus on a
different target population is not considered to be new and innovative. |
FOA Link: |
PAR-15-150 |
Cancer Education Grants Program - Courses for Skills Development
This FOA will support creative educational activities
with a primary focus on Courses for Skills
Development. Applications that propose innovative,
state-of-the-art programs, addressing the cause, diagnosis, prevention,
and treatment of cancer, rehabilitation from cancer, and the continuing
care of cancer patients and the families of cancer patients are
encouraged.
Amount & Project Period: |
$300,000/year (Direct Costs) - 5 years |
Eligibility: |
Established investigator at Associate Professor
level or above in scientific area in which application is targeted, and
capable of providing both administrative and scientific leadership to
development and implementation of proposed program. An application that
proposes to adapt a current or previously funded course to focus on a
different target population is not considered to be new and innovative. |
FOA Link: |
PAR-15-151 |
Cancer Education Grants Program - Research Experiences
This FOA will support creative educational activities
with a primary focus on Research
Experiences. Applications that propose innovative,
state-of-the-art programs, addressing the cause, diagnosis, prevention,
and treatment of cancer, rehabilitation from cancer, and the continuing
care of cancer patients and the families of cancer patients are
encouraged.
Amount & Project Period: |
$300,000/year (Direct Costs) - 5 years |
Eligibility: |
Established investigator at Associate Professor
level or above in scientific area in which application is targeted, and
capable of providing both administrative and scientific leadership to
development and implementation of proposed program. |
FOA Link: |
PAR-15-152 |
|
|
|
|
|
|
May 26 (LOI) |
All HOPA Members |
Non-federal |
Hematology Oncology |
The Hematology/Oncology Pharmacy Association (HOPA)
Foundation
2015 HOPA Research Fund Award
To support a hematology/oncology pharmacy practice research
project with subsequent publication. Pharmacy practice is
broadly defined including areas such as outcomes, surveys,
patient safety, standards validation, and translational science
applications. Multiple institutions may be involved in the
project, and co-PI projects are allowed.
Due Dates: |
May 26 (Letter of Intent)
Invited Apps: Sept. 03 (OSR) Ι Sept. 07 (Sponsor) |
Amount & Project Period: |
$50,000 - 1 year |
Eligibility: |
Open to all HOPA members |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
2015 HOPA Research Fund Award |
|
&
|
Exp. May 28
Int. June 03 |
All Ranks |
Federal |
Healthcare Research |
National Science Foundation & National Institutes of Health
Smart and Connected Health (SCH)
The goal of this interagency program is development of next generation
health and healthcare research through high-risk, high-reward
advances in understanding of and applications in information
science, technology, behavior, cognition, sensors, robotics,
bio-imaging, and engineering. Collaboration between academic,
industry, non-profit and other organizations is strongly
encouraged to establish better linkages between fundamental
science, clinical practice and technology development,
deployment and use.
Due Dates: |
Exploratory:
May 26 (OSR) Ι May 28 (Sponsor)
Integrative: June 1
(OSR) Ι June 03 (Sponsor)
|
Amount & Project Period: |
Exploratory:
$170,000/year (Direct Costs) - 3 years
Integrative: $370,000/year (Direct Costs) - 4 years
|
Eligibility: |
All Ranks - An investigator may participate as
PI, co-PI, Project Director, Senior Personnel or Consultant in no more
than two proposals submitted in response to this solicitation. |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
NSF-13-543 |
|
National Center for Complementary and Integrative Health
|
May 29 (LOI) |
All Ranks |
Federal |
Natural Product Testing |
Exploratory Clinical Trials and Studies of Natural Products
in NCCIH High Priority Research Topics
Support provided to confirm link between impact of natural
product on biological signature (i.e., mechanism of action) and
demonstrate an association between change in the biological
signature and clinical outcomes. Intention is to speed
translation of emerging basic science findings about natural
products into clinical pilot testing to determine whether
continued clinical research is warranted.
Due Dates: |
May 29 (Letter of Intent)
Applications: June 25 (OSR) Ι June 29 (Sponsor) |
Amount & Project Period: |
$450,000 (Total Direct Costs) - 3 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-AT-16-002 |
|
|
May 29 |
All Ranks |
Non-federal |
Drug Discovery |
Sanford Ι Burnham Medical Research Institute
Florida Translational Research Program
2015 Spring Call for Submissions
Concept or assay development
projects for use in pre-therapeutic discovery via
high-throughput screening - development of
innovative biochemical and cell-based assays for biological
targets, pathways, or processes for which there are limited
selective and potent small molecule modulators available
High-throughput screening
(HTS)-ready assays - well-developed, HTS-ready
assays suitable for high-throughput screening of the
Sanford-Burnham library of compounds for the purpose of
identifying small-molecule modulators of the target,
pathways, or processes of interest
Validated hits for the discovery of pre-therapeutic lead
compounds - proposals that aim to further
research and development of existing small-molecule chemical
scaffolds for use in vivo
Due Dates: |
May 27 (OSR) Ι May 29 (Sponsor) |
Amount & Project Period: |
No funding - 1 year
Provides access to
technological resources for drug development facilitating an
interdisciplinary, collaborative approach to the establishment of a
pipeline of potential new treatments for today's most challenging and
unmet medical needs. |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Link: |
Florida Translational Research Program at Sanford-Burnham |
|
|
May 29 |
All Ranks |
Federal |
Equipment |
Shared Instrumentation Grant (SIG) Program
Encourages applications from groups of NIH-supported
investigators to purchase or upgrade a single item of expensive,
specialized, commercially available instruments or integrated
systems. Types of instruments supported include: X-ray
diffraction systems, nuclear magnetic resonance (NMR) and mass
spectrometers, DNA and protein sequencers, biosensors, electron
and confocal microscopes, cell-sorters, and biomedical imagers.
Due Dates: |
May 27 (OSR) Ι May 29 (Sponsor) |
Amount & Project Period: |
Maximum: $600,000 - 1 year |
Eligibility: |
PD/PI should have documented technical
expertise directly related to chosen instrument.
Major User group of 3 or more individuals must be identified. Each must
be a PD/PI on a distinct NIH award with one of the following activity
codes: R01, DP1, DP2, P01, P50, R37, and U01. Major Users must have
substantial interests in and needs for the instrument.
Major Users can be researchers from the same department or from several
departments, divisions or schools at applicant institution, or from
nearby or regional institutions. |
Contact: |
Christi Craig (x1458) |
FOA Link: |
PAR-15-088 |
|
|
May 29 (LOI) |
All Ranks |
Federal |
Provocative Questions |
Research Answers to NCI's Provocative
Questions
Supports research projects designed to solve specific problems and
paradoxes in cancer research identified by the NCI Provocative
Questions initiative Intended to challenge cancer researchers to
think about and elucidate specific problems in key areas of
cancer research that are deemed important but have not received
sufficient attention.
Due Dates: |
May 29 (Letter of Intent) Ι June
25 (OSR) Ι June 29 (Sponsor)
Sept 20 (Letter of Intent) Ι Oct 27(OSR Ι Oct 29 (Sponsor) |
Amount & Project Period: |
Budgets not limited - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-CA-15-008 |
|
|
May 29 (LOI) |
All Ranks |
Federal |
Provocative Questions |
Research Answers to NCI's Provocative
Questions
Supports research projects designed to solve specific problems
and paradoxes in cancer research identified by the NCI
Provocative Questions initiative Intended to challenge cancer
researchers to think about and elucidate specific problems in
key areas of cancer research that are deemed important but have
not received sufficient attention.
Due Dates: |
May 29 (Letter of Intent) Ι June 25 (OSR) Ι June 29
(Sponsor)
Sept 20 (Letter of Intent) Ι Oct 27(OSR) Ι Oct 29 (Sponsor) |
Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
RFA-CA-15-009 |
|
(NEW) |
June 01 |
Jr Faculty |
Federal |
Career Dev |
CDMRP Peer Reviewed Cancer Research Program Career
Development Award
Supports independent, early-career investigators to conduct
research with the mentorship of an experienced cancer
researcher.
Due Dates: |
June 1 (Pre-application)
Invited submissions:
August 26 (OSR) | August 28 (Sponsor) |
Eligibility:
|
Independent investigator within 10 years of
completing degree |
Funding: |
$360,000 (Direct Costs) - 3 years |
Contact: |
Linda Nolan
(x6071) |
Link: |
W81XWH-15-PRCRP-CDA |
|
|
June 01 |
All Faculty |
Federal |
Military Cancer |
CDMRP PRCRP Idea Award with Special Focus
Supports high-risk/high-reward
concepts, theories, paradigms, and/or methods in cancer research.
The "Special Focus" of this award is on cancers
associated with conditions that are
unique to the military, or disproportionately represented in a
military population.
|
|
June 01 |
All Faculty |
Federal |
Health Disparities |
Ponce School of Medicine-Moffitt Cancer Center (PSM-MCC)
Partnership Research Project Funding Opportunity Cancer Health
Disparities
The Ponce School of Medicine-Moffitt Cancer Center
(PSM-MCC) Partnership invites faculty investigators to apply for
funds to develop a grant application featuring multiple PIs with
a goal of developing a competitive extramural proposal to
address cancer health disparities. Proposals must be in one of
the PSM-MCC Partnership target areas: Cancer Research, Cancer
Training, and Cancer Outreach.
Due Dates: |
Monday, June 1, 2015 by 4:00 pm (Submit as 1
email attachment to Sabrina Rodriguez at
sabrina.rodriguez@moffitt.org or Hannia Delgado at
hdegaldo@psm.edu |
Amount & Project Period: |
Full Projects: $125,000/institution ($250,000
Total)
Pilot Projects: $62,500/ institution ($125,000 Total)
Term is 2 years |
Eligibility: |
Only ranked faculty members are eligible
Must be a partnership between a faculty member from PSM and a faculty
member from Moffitt.
Submit 1 joint application w/2 PIs
Faculty members limited to 1 application submission as PI, but may be
listed as collaborators on additional applications. |
Contact: |
Sabrina Rodriguez (x6565) |
Links: |
Click here for Guidelines Ι
Click here for Application |
|
|
June 01 |
All Ranks |
Non-federal |
Pediatric Brain Cancer |
The Cure Starts Now Foundation
Research Grants
Funds search for a cure for brainstem glioma and other forms of
pediatric brain cancer in the hopes of curing all cancers Focus
is on Diffuse Intrinsic Brainstem Glioma (DIPG), and to support
translational and clinical research projects in those areas.
Due Dates: |
May 28 (OSR) Ι June 01 (Sponsor) (Hardcopy
by June 5th) |
Amount & Project Period: |
$100,000 - 1 year |
Eligibility: |
All Ranks |
Contact: |
Shaina
Sine (x3658) |
Link: |
Research & Grants |
|
NEW |
June 01 |
All Faculty |
Moffitt |
Neuro-Oncology, Sarcoma or
Adolescent & Young Adults (AYA) |
Chotiner Pediatric
Research Pilot Funding Opportunity
Moffitt Leadership is pleased to announce a pilot funding opportunity
focused on Pediatric Cancer with preference given to proposals
in Neuro-Oncology, Sarcoma or a focus on Adolescent & Young
Adults (AYA).
|
NEW |
June 01 |
All Ranks |
Moffitt |
CT-Minority Accruals |
Moffitt Clinical Trial Funding Opportunity
Clinical trial funding w/emphasis on increasing minority accrual.
Investigator-initiated phase 0, I, or II intervention, including
therapeutic, supportive care and prevention clinical trial
addressing an underrepresented group; potentially increasing
minority subject accrual.
Due Dates: |
June 01 (by 4:00pm) to
Maureen.ahearn@moffitt.org |
Amount & Project Period: |
Maximum of $100,000 for clinical
trial (incl. trial coord, data mgmnt., non-billable lab tests, etc.).
Up to $50,000 for correlative science (incl. shared resources,
research lab supplies and tech support). |
Eligibility: |
All Ranks |
Contact: |
Maureen Ahearn (X8824) |
RFA Link: |
RFP for Clinical Trial Funding |
|
NEW |
June 02 (Pre-application) |
See Below |
Federal |
Lung Cancer |
Congressionally Directed Medical Research Programs (CDMRP)
Lung Cancer Research Program (LCRP)
Due Dates: |
June 02 (Pre-application)
Invited Submissions: Sept. 14 (OSR) Ι Sept. 16 (Sponsor) |
Contact: |
Linda
Nolan (x6071) |
Career Development Award W81XWH-15-LCRP-CDA
To conduct
impactful research under the mentorship of an experienced
lung cancer researcher An opportunity to obtain funding,
mentoring, and experience necessary for productive,
independent careers at forefront of lung cancer research.
Award is intended to support impactful research projects
with an emphasis on discovery.
Amount & Project Period: |
$240,000 (Direct Costs) - 2 years |
Eligibility: |
PI: Asst. Professor w/in 5
years of first faculty appt. and having 40% protected time for proposed
research
Mentor: (Associate Professor or above) having a proven
publication and funding record in lung cancer research |
PA Link: |
LCRP_CDA_ W81XWH-15-LCRP-CDA |
|
|
Clinical Exploration Award W81XWH-15-LCRP-CEA
Supports rapid execution of hypothesis-driven, early-phase
clinical trials to examine interventions that could have a major
impact on lung cancer clinical management. Supports innovative,
hypothesis-based correlative studies derived from ongoing or
completed clinical trials. Must include documentation of an
existing Investigational New Drug (IND) or Investigational
Device Exemption (IDE), if applicable
Amount & Project Period: |
$450,000 (Direct Costs) - 3 years (Clinical
Trial)
$250,000 (Direct Costs) - 2 years (Correlative Studies) |
Eligibility: |
Independent investigators at or above the level
of Assistant Professor (or equivalent) |
PA Link: |
CEA_LCRP_ W81XWH-15-LCRP-CEA |
|
|
Idea Development Award W81XWH-15-LCRP-IDA
Supports conceptually innovative, high-risk/high-reward research
that could lead to critical discoveries or major advancements
that will accelerate progress toward eradicating deaths from
lung cancer Applications should include a well-formulated,
testable hypothesis based on strong scientific rationale.
Amount & Project Period: |
$350,000 (Direct Costs) - 2
years |
Eligibility: |
Assistant Professor or above (New investigator
applications encouraged/(peer and programmatically reviewed separately) |
PA Link: |
IDA_LCRP_ W81XWH-15-LCRP-IDA |
|
|
June 03 |
Jr Faculty |
Non-federal |
Prostate |
Prevent Cancer Foundation
2015 PCF Young Investigator Awards
Applicants may be working in basic, translational, or clinical research; need not be trained specifically in prostate cancer
research. However, successful applicants should be working in a
research environment capable of supporting transformational
prostate cancer research. Access to and interaction with a
clinical environment, as well as translational prostate cancer
physician-scientists, is highly desirable.
Due Dates: |
June 01 (OSR) Ι June 03 (by
3:pm (EDT) Sponsor)) |
The
online application submission portal will go live at
https://pcf.smartsimple.com on Friday, April 17,
2015. Please direct questions to
applications@pcf.org |
|
Amount & Project Period: |
$75,000/year - 3 years |
Eligibility: |
Should be w/in 6 years of completing a
professional degree or clinical training such as MD, PhD, DSc, MD-PhD or
equivalent and hold the title of Senior Postdoctoral Fellow, Instructor,
Research Associate, Assistant Professor, or equivalent. Must be under
direct supervision of a mentor. Applicants should have received no
more than $200,000 in current direct research funding from all sources
including institutional funds. |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
Request for Applications Ι
Prevent Cancer Foundation |
|
Cycle II Due Date for new
submissions |
June 05 |
All Ranks |
Federal |
Research Support |
Research Grants and Cooperative Agreements
An R01 is used
to support a discrete, specified, circumscribed research project
with no specific dollar amount unless specified in the FOA
(advance permission required for direct costs of $500K or more
in any year). These are usually awarded for 3-5 years.
A U01 is similar with the exception that there is substantial
programmatic involvement from the Awarding Institute and Center.
Due Dates: |
June 03 (OSR) Ι June 05 (Sponsor) |
Amount & Project Period: |
Budgets not limited - 5 years |
Eligibility: |
All ranks, unless otherwise specified |
Contact: |
Linda
Nolan (x6071) |
|
NEW |
June 05 |
All Ranks |
Federal |
Early Life Factors & Cancer |
Early-life Factors and Cancer Development Later in Life
Research focused on role of early-life factors in cancer
development later in life. It is necessary to better understand
1) Early-life (maternal-paternal, in utero, birth and infancy,
puberty and adolescence, and teenage and young adult years)
factors associated with later cancer development; 2) How
early-life factors mediate biological processes relevant to
carcinogenesis; and 3) Whether predictive markers for cancer
risk based on what happens biologically at early-life can be
measured and developed for use in cancer prevention strategies.
Due Dates: |
Standard dates June 03 (OSR) Ι June 05 (Sponsor) |
Amount & Project Period: |
Budgets are not limited - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
(PA-15-126) |
|
National Institute of Allergies & Infectious Diseases
NEW
|
June 05 |
All Ranks |
Federal |
Immunodeficiency |
Investigations on Primary Immunodeficiency Diseases
Supports innovative investigations in primary immunodeficiency
diseases. Of particular interest are detection of primary
immunodeficiency diseases, identification of molecular basis,
and design and pre-clinical development of innovative therapies
for these diseases.
Due Dates: |
Standard dates June 03 (OSR) Ι June 05 (Sponsor) |
Amount & Project Period: |
Budgets are not limited - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Link: |
PAR-15-130 |
|
NEW |
June 05 |
All Ranks |
Federal |
Probiotic/Prebiotic & Human Microbiome
|
Advancing Translational and Clinical Probiotic/Prebiotic and
Human Microbiome Research
NCI plans to support rigorous translational and clinical studies
to promote cancer prevention and treatment and to understand the
molecular processes (including how pro/prebiotics compete with
pathogens, increase the production of protective metabolites and
reduce the production of pro-carcinogens, etc.) with the aim to
determine how a person's risk of developing cancer or cancer
treatment outcomes can be modified by pro/prebiotics.
Due Dates: |
Standard dates June 03 (OSR) Ι June 05 (Sponsor) |
Amount & Project Period: |
Budgets are not limited - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-15-127 |
|
NEW |
June 08 |
All Faculty |
Non-federal |
Female Cancers |
The Foundation for Women's Wellness
Research Awards
Small, short-term studies with promise for improving medical knowledge in
leading female cancers, role of hormones in disease and
stage-of-life health issues, and diseases disproportionately
affecting women.
Due Dates: |
June 04 (OSR) Ι June 08 (Sponsor) |
Amount & Project Period: |
$25,000 - 1 year |
Eligibility: |
Must be an M.D. and/or Ph.D. with a faculty
appointment (assistant professor, or higher) |
Contact: |
Linda
Nolan (x6071) |
Link: |
Research Awards |
|
NEW |
June 08 (LOI) |
All Ranks |
Federal |
Cancer Epidemiology Cohorts (CECs) |
Core Infrastructure and Methodological Research for Cancer
Epidemiology Cohorts
Applications for targeted infrastructure support of core
functions of Cancer Epidemiology Cohorts (CECs) and
methodological research. NCI will support infrastructure and
core functions for existing or new CECs, and will also lead to
support of core functions for CECs currently funded through
other grant mechanisms by the Epidemiology and Genomics Research
Program (EGRP) and other components of the Division of Cancer
Control and Population Sciences (DCCPS) at NCI.
Due Dates: |
June 08 (Letter of Intent)
Applications: July 06 (OSR) Ι July 08 (Sponsor) |
Amount & Project Period: |
Direct Costs for any year not to exceed $2.5M -
5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-104 |
|
|
June 11 (Pre-application) |
All Faculty |
Federal |
See Below |
Congressionally Directed Medical Research Programs (CDMRP)
Peer Reviewed Medical Research Program (PRMRP)
|
|
Pre-applications Due: |
June 11 |
Eligibility: |
Assistant Professor level or above |
Contact: |
Linda
Nolan (x6071) |
|
NEW |
Investigator-Initiated Research Award
W81XWH-15-PRMRP-IIRA
Projects may focus on any phase of research from basic
laboratory research through translational research, including
preclinical studies in animal models and human subjects, as well
as correlative studies associated with an existing clinical
trial. Research involving human subjects and human anatomical
substances is permitted, but cannot be used to conduct clinical
trials.
Invited Submissions Due: |
October 13 (OSR) Ι October 15 (Sponsor) |
Amount & Project Period: |
$1.2M (Direct Costs) - 3 years
$1.5M (Direct Costs) - 3 years (Includes Partnering Option) |
Link: |
W81XWH-15-PRMRP-IIRA
|
|
NEW |
Technology/Therapeutic Development Award
W81XWH-15-PRMRP-TTDA
Product-driven award mechanism intended to provide support for
translation of promising preclinical findings into products for
clinical applications, including prevention, detection,
diagnosis, treatment, or quality of life
Invited Submissions Due: |
October 13 (OSR) Ι October 15 (Sponsor) |
Amount & Project Period: |
$1.8M (Direct Costs) - 3 years |
Link: |
W81XWH-15-PRMRP-TTDA |
|
Cycle II Due Date for new
submissions |
June 12 |
All Ranks |
Federal |
Career Development |
K-Series
Awards for candidates who wish to further develop their careers
in biomedical, behavioral an clinical research. Applicants are
generally required to hold a research or health - professional
doctoral degree or its equivalent; eligibility for some Career Development Awards is
limited to only applicants with health professional doctoral
degrees.
Due Dates: |
June 10 (OSR) Ι June 12 (Sponsor) |
Amount & Project Period: |
Funding varies depending on type of K-Award and
Institute or Center, usually includes salary support and some funds for
research. Duration is up to 5 years |
Eligibility: |
Dependent on Type of K-award |
Contact: |
Linda
Nolan (x6071) |
Link: |
Information about NIH Career Development Awards |
|
NEW |
June 16 |
All
Ranks |
Federal |
Early Life factors &
Cancer |
Early-life Factors and Cancer Development Later in Life
Research focused on role of early-life factors in cancer
development later in life. It is necessary to better understand
1) Early-life (maternal-paternal, in utero, birth and infancy,
puberty and adolescence, and teenage and young adult years)
factors associated with later cancer development; 2) How
early-life factors mediate biological processes relevant to
carcinogenesis; and 3) Whether predictive markers for cancer
risk based on what happens biologically at early-life can be
measured and developed for use in cancer prevention strategies.
Due Dates: |
Standard dates June 12 (OSR) Ι June 16 (Sponsor) |
Amount & Project Period: |
R21: $275,000 (Direct Costs) - 2 years
R03: $100,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Links: |
R21:
PA-15-125 Ι R03:
PA-15-124 |
|
NEW |
June 16 |
All Ranks |
Federal |
Healthcare |
Agency for Healthcare Research and Quality
AHRQ Small Research Grant Program (R03)
AHRQ's specific priority areas of focus are:
1)
Improve health care quality by accelerating
implementation of Patient Centered Outcomes
2)
Research (PCOR)
3)
Make health care safer
4)
Increase accessibility by evaluating expansions of
insurance coverage
5)
Improve health care affordability, efficiency and cost
transparency
Due Dates: |
Standard dates Ι June 12 (OSR) Ι June 16 (Sponsor) |
Amount & Project Period: |
$100,000 (Total Costs) - 2 years |
Eligibility: |
All Ranks - Only 1 PD/PI allowed on application |
Contact: |
Linda Nolan (x6071) |
FOA Link: |
PA-15-147 |
|
NEW |
June 16 |
All Ranks |
Federal |
Digestive Diseases and Nutrition |
Pilot and Feasibility Clinical Research Studies in Digestive
Diseases and Nutrition
Encourages pilot and feasibility clinical and epidemiological
research studies of new therapies or means of health promotion
and prevention of digestive and liver diseases and nutritional
disorders associated with digestive and liver diseases.
Due Dates: |
Standard dates Ι June 12 (OSR) Ι June 16 (Sponsor) |
Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-12-139 |
|
Cycle II Due Date for new
submissions |
June 16 |
All Ranks |
Federal |
Research Support |
Other Research Grants
The
Small Grant Program (R03) Provides limited funding
for a short period of time to support a variety of types of
projects, including: pilot or feasibility studies, collection of
preliminary data, secondary analysis of existing data, small,
self-contained research projects, development of new research
technology, etc.
The Exploratory/Developmental Research Grant Award (R21)
encourages new, exploratory and developmental research projects
by providing support for the early stages of project
development. Sometimes used for pilot and feasibility studies.
Due Dates: |
June 12 (OSR) Ι June 16 (Sponsor) |
Amount & Project Period: |
R03: $100,000 (Direct Costs) - 2
years
R21: $275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks, unless otherwise specified |
Contact: |
Linda
Nolan (x6071) |
|
NEW FOA # |
June 17 |
All Ranks |
Federal |
Health Disparities |
Exploratory/Developmental Grants Program for Basic Cancer
Research in Cancer Health Disparities
Basic research studies into the biological/genetic causes and
mechanisms of cancer health disparities.
Due Dates: |
June 15 (OSR) Ι June 17 (Sponsor) |
Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-092 |
|
NEW FOA # |
June 17 |
All Ranks |
federal |
Health Disparities |
Basic Cancer Research in Cancer Health Disparities
To investigate biological/genetic bases of cancer disparities,
such as (1) mechanistic studies of biological factors associated
with cancer disparities, including those related to basic
research in cancer biology or cancer prevention intervention
strategies, (2) development & testing of new methodologies &
models, and (3) secondary data analyses
Due Dates: |
June 15 (OSR) Ι June 17 (Sponsor) |
Amount & Project Period: |
$250,000 (Direct Costs) - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
PAR Link: |
PAR-15-093 |
|
|
June 18 (Pre-application) |
All Faculty |
Federal |
See Below |
Congressionally Directed Medical Research Programs (CDMRP)
Peer Reviewed Medical Research Program (PRMRP)
Pre-applications Due: |
June 18 |
Eligibility: |
Assistant Professor level or
above |
Contact: |
Linda Nolan (x6071) |
|
NEW |
Clinical Trial Award
W81XWH-15-PRMRP-CTA
Supports rapid implementation of clinical trials w/potential to
have a significant impact on a disease or condition addressed in
at least one Congressionally -directed FY15 PRMRP Topic Areas
Clinical trials may be designed to evaluate promising new
products, pharmacologic agents (drugs or biologics), devices,
clinical guidance, and/or emerging approaches and technologies.
Invited Applications Due: |
October 20 (OSR) Ι October 22 (Sponsor) |
Amount & Project Period: |
Not restricted to predetermined amount - 5
years |
Link: |
W81XWH-15-PRMRP-CTA |
|
NEW |
Focused Program Award
W81XWH-15-PRMRP-FPA
Synergistic, multidisciplinary research programs:
1. Must describe a
unifying, overarching challenge to be addressed by a set of
research projects.
2. Shall include multiple, distinct research
projects led by individual project leaders addressing
complementary aspects of overarching challenge
3. Research strategy
to address overarching challenge must be supported by detailed
plan identifying critical milestones; outlining knowledge,
resources, and technical innovations to be utilized to achieve
milestones; and explaining how outcomes will be translated to
patients Partnering Pi option is available for this award
Invited Applications Due: |
October 26 (OSR) Ι October 28 (Sponsor) |
Amount & Project Period: |
$1.2M (Direct Costs) - 3 years
$1.5M (Direct Costs) - 3 years (Partnering PI Option) |
Link: |
W81XWH-15-PRMRP-FPA
|
|
NEW FOA # |
June 22 |
All Ranks |
Federal |
Career Development |
Exploratory Grant Award to Promote Workforce Diversity in
Basic Cancer Research
Supports eligible investigators from groups that have been shown
to be underrepresented in the biomedical, clinical, behavioral,
and social sciences workforce. Provides a bridge to
investigators that have completed their research training and
may need extra time to develop a larger research project grant
application.
Due Dates: |
June 18 (OSR) Ι June 22 (Sponsor) |
Amount & Project Period: |
$275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PAR-15-053 |
|
NEW |
June 22 |
Postdocs/Jr faculty |
Non-federal |
Cancer Biomarkers |
ASCO, EORTC, and NCI
Markers in Cancer Diagnostic Development Tutorial
WHEN: December 1-2, 2015 (Tutorial)
December 3-4 (Innovation
& Biomarkers in Cancer Drug
Development mtg)
WHERE: The Hotel, Boulevard
de Waterloo, 38 1000 Brussels, Belgium
Tutorial is sponsored by NCI, the American Society
of Clinical Oncology, and the European Organization for Research
and Treatment of Cancer. The tutorial will precede the
Innovation and Biomarkers in Cancer Drug Development (IBCD)
Conference. Upon completion, participants will be able to:
1. Describe potential hypotheses & relevant endpoints that
could be used to evaluate markers for different clinical uses
2. Recognize importance of standardization of assay
procedures early in development process, to include
characterization of both analytic & clinical performance of
assay
3. Review statistical principles that should guide
development of single analyze and multiplex tests
4. Evaluate appropriateness of various clinical study designs
for at least 1 type of marker
5. Identify differences in regulatory options and
requirements (US and European) to bring new cancer biomarkers to
market
Due Dates: |
Grant applications: June 22
(Sponsor) |
Amount & Project Period: |
Free Registration for tutorial
Assistance w/hotel accommodations |
Eligibility: |
Physicians and/or scientists
w/in 8 years of obtaining MD, PhD or both
Familiar with the basics of Clinical Trial Design
Working on Biomarkers or Molecular Diagnostics and on a project which is
ready for clinical development |
Contact: |
Linda
Nolan (x6071) |
Link: |
Markers in Cancer Diagnostic Development Tutorial |
|
NEW |
June 25 |
All Ranks |
Federal |
See Below |
Congressionally Directed Medical Research Programs (CDMRP)
Peer Reviewed Medical Research Program (PRMRP)
Discovery Award
W81XWH-15-PRMRP-DA
- The intent of this award is to support innovative,
untested, high-risk/ potentially high-reward research
providing new insights, paradigms, technologies, or
applications
- Proposed project should include a well-formulated,
testable hypothesis based on a sound scientific rationale
and study design
- Proposed research project should be novel and innovative
- Inclusion of preliminary data is strongly discouraged
- Not intended to support a logical progression of an
already established research project or other types of
ongoing work
Due Dates: |
June 25 (Pre-application)
Applications: July 07 (OSR) Ι July 09 (Sponsor) |
Amount & Project Period: |
$200,000 - (18 months) |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Link: |
W81XWH-15-PRMRP-DA |
|
|
June 30 |
All Ranks |
Non-federal |
Leukemia | \
Children's Leukemia Research Association, Inc.
Research Grants
Funds the most promising studies to isolate the causes of
leukemia.
Due Dates: |
June 26 (OSR) Ι June 30 (Sponsor) |
Amount & Project Period: |
$30,000 - 1 year |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Link: |
Research
Grants |
|
NEW |
July 01 |
Postdocs |
Non-federal |
Career Development |
Helen Hay Whitney
Foundation Research Fellowship
Grants financial support of sufficient duration to help further
the careers of young men and women engaged in basic biological
or medical research.
Due Dates: |
June 29 (OSR) Ι July 01 (Sponsor) |
Amount & Project Period: |
Yr 01: $51,000 (Stipend) - $1,500 (Allowance)
Yr 02: $52,000 (Stipend) - $1,500 (Allowance)
Yr 03: $53,000 (Stipend) - $1,500 (Allowance) |
Eligibility: |
Hold, or be in final stages of obtaining PhD,
MD, or equivalent
Have < 1 year of
postdoctoral research experience as of due date and who have received a
PhD <
2 years before due date, or MD degree
< 3 years before due date. |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
Research
Fellowships |
|
NEW |
July 01 |
All Ranks |
Non-federal |
Lung |
Lung Cancer Research Foundation
2014 Research Grants
Medical/scientific research projects covering all aspects of
lung cancer research Grants are awarded for lung cancer projects
focused on one or more of the following: 1) Basic science
2) Translational research 3) Clinical research 4) Supportive care
5) Quality of care/outcomes
Due Dates: |
June 29 (OSR) Ι July 01 (Sponsor) |
Amount & Project Period: |
$75,000 - 1 year |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
Link: |
2015 Research Grants |
|
|
July 01 |
Jr. Faculty |
Non-federal |
Career Development |
Damon Runyon Cancer Research Institute
Innovation Award
To provide funding to extraordinary early career researchers who have an
innovative new idea but lack sufficient preliminary data to
obtain traditional funding.
Due Dates: |
June 29 (OSR) Ι July 01 (Sponsor)
by 4:00pm ET |
Amount & Project Period: |
$150,000/year - 2 years (with opportunity for up
to 2 additional years) |
Eligibility: |
Applicants must belong to one
of the following:
Tenure-track Assistant
Professors w/in first 4 years of initial Assistant Professor position (Cut-off date: July 1,
2011.)
Clinical Instructors and
Senior Clinical Fellows (in final year of sub-specialty training) holding an MD and pursuing a period of independent research before a tenure-track faculty position.
Applicants are expected
to commit a minimum of 80% FTE to conducting research. |
Contact: |
Linda
Nolan (x6071) |
Links: |
Overview Ι
Application Guidelines |
|
Cycle II
Renewals,
Resubmissions, Revisions |
July 05 |
All Ranks |
Federal |
Research Projects |
Research Grants and Cooperative Agreements
An R01 is used to support a discrete, specified, circumscribed
research project with no specific dollar amount unless specified
in the FOA (advance permission required for direct costs of
$500K or more in any year). These are usually awarded for 3-5
years. A U01 is similar with the exception that there is
substantial programmatic involvement from the Awarding Institute
and Center.
Due Dates: |
Standard Due Dates Ι July 02 (OSR) Ι July 05 (Sponsor) |
Amount & Project Period: |
Budgets not limited - 5 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
FOA Link: |
PA-13-302 (Current Parent)
and other FOAs as published |
|
Cycle II
Renewals,
Resubmissions, Revisions |
July 12 |
All Ranks |
Federal |
Career Development |
Research Career Development Awards
Awards for candidates who wish to further develop their careers in
biomedical, behavioral an clinical research. Applicants are
generally required to hold a research or health - professional
doctoral degree or its equivalent; eligibility for some Career
Development Awards is limited to only applicants with health
professional doctoral degrees.
|
Cycle II
Renewals,
Resubmissions, Revisions |
July 16 |
All Ranks |
Federal |
Research Projects |
Other Research Grants
The Small Grant Program (R03)
Provides limited funding for a short period of time to support a
variety of types of projects, including: pilot or feasibility
studies, collection of preliminary data, secondary analysis of
existing data, small, self-contained research projects,
development of new research technology, etc.
The Exploratory/Developmental
Research Grant Award (R21) encourages new,
exploratory and developmental research projects by providing
support for the early stages of project development. Sometimes
used for pilot and feasibility studies
Due Dates |
Standard Due Dates Ι July 14 (OSR) Ι July 16 (Sponsor) |
Amount & Project Period: |
R03: $100,000 (Direct
Costs) - 2 years
R21: $275,000 (Direct Costs) - 2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (x6071) |
|
NEW |
July 31 |
All Faculty |
Non-federal |
Cutaneous Lymphoma |
Cutaneous Lymphoma Foundation (CLF)
Research Awards Program (RAP) 2015 CLARIONS Grant
Funds innovative research in all areas of cutaneous lymphomas with
particular interest in:
• |
Etiology and risk factors of cutaneous lymphomas
|
• |
Measures of disease impact on individuals &
populations affected |
• |
Translating discoveries into diagnostic and
therapeutic advances in cutaneous lymphomas |
• |
Optimizing therapies for cutaneous lymphomas |
|
Retirement
Research Foundation
NEW |
August 01 |
All Ranks |
Non-federal |
Elderly Populations |
The Retirement Research Foundation
Responsive Grants Program
Grants will be awarded to projects that provide direct services,
advocacy, education, and/or training programs for professionals
working with elders, as well as for research that investigates
causes and solutions to significant problems of older adults.
Due Dates: |
July 30 (OSR) Ι August 01(Sponsor) |
Amount & Project Period: |
$$ not specified- generally 1-2 years |
Eligibility: |
All Ranks |
Contact: |
Linda
Nolan (X6071) |
RFA Link: |
Responsive Grants |
|
Cycle II
F Series
Fellowships (exc. F31 Diversity) New, Renewal, Resubmission |
August 08 |
Postdocs/Fellows |
Federal |
Career Development |
F-Series Fellowships
An NIH training program award where the NIH specifies the
individual receiving the award. Fellowships comprise the F
activity codes Each NIH fellowship program is
announced as a Funding Opportunity Announcement (FOA)
Due Dates |
August 06 (OSR) Ι August 08 (Sponsor) |
Amount & Project Period: |
Stipend plus training allowance |
Eligibility: |
Varies among programs |
Contact: |
Linda
Nolan (x6071) |
|
Cycle II
F31 Diversity Predoctoral fellowships
New, Renewal, Resubmissions |
August 13 |
Graduate Students |
Federal |
Career Development |
F31 Diversity
Fellowship
Individual Predoctoral Fellowships (F31) to Promote Diversity in
Health-Related Research
Due Dates: |
August 11 (OSR) Ι August 13
(Sponsor) |
Amount & Project Period: |
Stipend plus training allowance |
Eligibility: |
Enrolled graduate student |
Contact: |
Linda
Nolan (x6071) |
|
NEW |
August 17 |
Postdocs/Fellows |
Non-federal |
Career Development |
Damon Runyon Cancer Research Foundation
Damon Runyon Fellowship Award
Supports all theoretical and experimental research relevant to
the study of cancer and the search for cancer causes,
mechanisms, therapies and prevention
Due Dates: |
August 13 (OSR) Ι August
17(Sponsor) |
Amount & Project Period: |
Level 1: Stipend: $50,000/year;
Allowance: $2,000/year
Level 2: Stipend: $60,000/year; Allowance: $2,000/year |
Eligibility: |
Level 1 Funding:
Basic and physician-scientist
degree received < 1 year prior to the Fellowship Award
Committee (FAC) meeting when application is to be considered, and not
have been in Sponsor's lab >1 year prior to meeting.
Level 2 Funding:
Physician-scientist applicant (MD, MD/PhD, DDS, DVM or equiv.) must have
completed residency & clinical training and be board-eligible in U.S. at
award.
Postdoctoral fellows, clinical fellows and clinical instructors are
eligible to apply. Foreign candidates may apply to do research only in
U.S.
|
Contact: |
Linda
Nolan (X6071) |
Link: |
Fellowship Application Guidelines |
|
NEW |
August 21 |
Established Investigators |
Non-federal |
Gastric Cancer |
AGA Research Foundation
Robert & Sally Funderburg Research Award in Gastric Cancer
To support the research of an established investigator working
on novel approaches to gastric cancer.
Due Dates: |
August 19 (OSR) Ι August 21 (Sponsor) |
Amount & Project Period: |
$50,000/year - 2 years |
Eligibility: |
Must be established, independent investigator
in gastric biology
AGA membership required at time of submission |
Contact: |
Linda
Nolan (x6071) |
RFA Link: |
Application and Overview |
|